Literature DB >> 11440544

Neutrophil activation induced by placental factors in normal and pre-eclamptic pregnancies in vitro.

Y Wang1, Y Gu, L Philibert, M J Lucas.   

Abstract

Increased neutrophil activation has been demonstrated in women with pre-eclampsia. Activated neutrophils may play a significant role in the vascular endothelial pathophysiology in this disorder of pregnancy. How neutrophils become activated in pre-eclampsia is unknown. It has been proposed that activating factors could be produced and released by the placenta. To test if placental factors could stimulate neutrophil activation and what mechanism might be involved, neutrophils isolated from healthy female volunteers were exposed to the conditioned medium (CM) derived from either normal (Nor) or pre-eclamptic (PE) placental villous culture. Neutrophil-endothelial adhesion, neutrophil superoxide generation, elastase activity and integrin expression were measured. The data were analysed by ANOVA. A P value less than 0.05 was considered statistically significant. All values are expressed as a mean+/-s.e. We found: (1) neutrophil-endothelial adhesion was significantly increased in neutrophils exposed PE-CM than those exposed to Nor-CM and non-CM, P< 0.01; (2) both Nor-CM and PE-CM could stimulate neutrophils to generate more superoxide radicals; (3) there was no difference in elastase activity after neutrophil exposure to Nor-CM compared to PE-CM, P> 0.1; (4) significant changes in CD62L and CD11b expression were found in neutrophils exposed to PE-CM. We conclude that factors produced by the placenta can activate neutrophils by an increase in superoxide generation and modulation of adhesion molecule expression. Upregulation of surface adhesion molecule CD11 expression may be responsible for the increased neutrophil-endothelial adhesion induced by factors derived from pre-eclamptic placentae. Copyright 2001 Harcourt Publishers Ltd.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11440544     DOI: 10.1053/plac.2001.0691

Source DB:  PubMed          Journal:  Placenta        ISSN: 0143-4004            Impact factor:   3.481


  20 in total

1.  Molecular and vascular targets in the pathogenesis and management of the hypertension associated with preeclampsia.

Authors:  Ossama M Reslan; Raouf A Khalil
Journal:  Cardiovasc Hematol Agents Med Chem       Date:  2010-10-01

Review 2.  Genetic, immune and vasoactive factors in the vascular dysfunction associated with hypertension in pregnancy.

Authors:  Sajjadh M J Ali; Raouf A Khalil
Journal:  Expert Opin Ther Targets       Date:  2015-08-17       Impact factor: 6.902

3.  Chymotrypsin-like protease (chymase) mediates endothelial activation by factors derived from preeclamptic placentas.

Authors:  J Steven Alexander; Lynn J Groome
Journal:  Reprod Sci       Date:  2009-06-03       Impact factor: 3.060

4.  Elevated maternal soluble Gp130 and IL-6 levels and reduced Gp130 and SOCS-3 expressions in women complicated with preeclampsia.

Authors:  Yuping Wang; David F Lewis; Yang Gu; Shuang Zhao; Lynn J Groome
Journal:  Hypertension       Date:  2010-12-20       Impact factor: 10.190

5.  Preventive and therapeutic potential of placental extract in contact hypersensitivity.

Authors:  Youn Son Kim; Jang-June Park; Yukimi Sakoda; Yuming Zhao; Katsuya Hisamichi; Tai-Ichi Kaku; Koji Tamada
Journal:  Int Immunopharmacol       Date:  2010-07-07       Impact factor: 4.932

6.  The effect of Silymarin on VEGF, VEGFR-1 and IL-1α levels in placental cultures of severe preeclamptic women.

Authors:  Mustafa Derda Kaya; Eralp Başer; Sibel Kaya; Mustafa Kemal Takal; Feride Sahin; Esra Kuşçu; Filiz Yanık
Journal:  J Turk Ger Gynecol Assoc       Date:  2014-03-01

7.  Prevention of Defective Placentation and Pregnancy Loss by Blocking Innate Immune Pathways in a Syngeneic Model of Placental Insufficiency.

Authors:  Shari E Gelber; Elyssa Brent; Patricia Redecha; Giorgio Perino; Stephen Tomlinson; Robin L Davisson; Jane E Salmon
Journal:  J Immunol       Date:  2015-06-12       Impact factor: 5.422

8.  Vasoreactivity of chorionic plate arteries in response to vasoconstrictors produced by preeclamptic placentas.

Authors:  C Benoit; J Zavecz; Y Wang
Journal:  Placenta       Date:  2006-10-27       Impact factor: 3.481

9.  Increased Neutrophil Activation and Plasma DNA Levels in Patients with Pre-Eclampsia.

Authors:  Yae Hu; Hui Li; Ruhong Yan; Can Wang; Yun Wang; Ce Zhang; Meng Liu; Tiantian Zhou; Weipei Zhu; Hong Zhang; Ningzheng Dong; Qingyu Wu
Journal:  Thromb Haemost       Date:  2018-11-19       Impact factor: 5.249

Review 10.  Oxidative stress in the placenta.

Authors:  Leslie Myatt; Xiaolan Cui
Journal:  Histochem Cell Biol       Date:  2004-07-10       Impact factor: 4.304

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.